INDENA’S CDMO SERVICES: THE FORMULA FOR CLIENTS’ SUCCESS

Indena’s Custom Development & Manufacturing Organization (CDMO) services offer a full range of manufacturing capabilities for pharmaceutical ingredients. In a challenging CDMO framework, projects for customers can be very diversified…

Small is Powerful: A Globally Unique Capability for Nanoforming HPAPIs

By Dr. David Rowe – Head of Manufacturing and Antonio da Silva – Senior Director Business Operations, Nanoform In oncology and the wider pharmaceutical market, there is a surge in…

5 MINUTES WITH: Mikael Hagstroem, CEO, LabVantage Solutions
By

By
DCAT Value Chain Insights’ “5 Minutes With,” part of the DCAT Member Company Community section, features interviews with business and industry leaders on issues impacting the bio/pharmaceutical manufacturing value chain.…

CDMOs Ride Momentum into 2022
By

By
By Jim Miller, Content Advisor/Consultant, DCAT. The CDMO sector experienced a strong 2021, but the question for 2022 is whether momentum continues as macroeconomic headwinds create uncertainty.

Top Biomanufacturing Trends for 2022
By

By
By Joel Ranck, Market Analyst, BioPlan Associates. What are key trends impacting biomanufacturing for 2022? COVID supply-chain challenges, unpredictable growth capacity, and China are major concerns.